Agenda/Scientific Program

View the Scientific Program

The Symposium will bring together key industry thought leaders to discuss topics such as current perspectives, strategies, and technologies used for bioassays. Speaker presentations, panel discussions, and poster sessions will give you the opportunity to engage with fellow attendees in meaningful discussions. We look forward to an informative Symposium and hope to see you there. Be ready to network, collaborate, and expand your knowledge.

The session topics for 2025 include:

• ADCs
• Bispecifics and Trispecifics
• Bioassay Foundations/Nuts and Bolts
• Cell and Gene Therapy
• Emerging Technologies/Innovations in Bioassays

Ned Mozier received a PhD in biochemistry at the University of Louisville and was employed in the pharmaceutical industry for 35 years, retiring in 2024. At Pfizer, Inc., he held a number of scientific roles, including leadership of Pfizer’s bioassay and impurity group for 10 years. His last job at Pfizer was as Vice President for CMC development for Pfizer’s large molecule and vaccine early clinical portfolio. Mozier has contributed to the development and commercialization of many biological products and vaccines. Throughout his career, he has published and led conferences championing the use of in vitro alternatives to animal testing. He continues to speak at scientific conferences and lead USP committees and panels.